Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of 89bio, Inc. (NasdaqGM: ETNB) to Roche Holding ...

We recently published 10 Stocks Stole the Show, 5 Hit Historic Highs. 89bio Inc. (NASDAQ:ETNB) is one of the best performers ...

Fintel reports that on September 19, 2025, HC Wainwright & Co. downgraded their outlook for 89bio (NasdaqGM:ETNB) from Buy to ...

Fintel reports that on September 19, 2025, Wolfe Research downgraded their outlook for 89bio (NasdaqGM:ETNB) from Outperform ...

Roche acquires 89bio for up to $3.5B, betting on pegozafermin for MASH. Click here to read the latest analysis on ETNB and ...

Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since ...

Roche is set to acquire 89bio for $3.5B, adding late-stage MASH drug pegozafermin to its cardiovascular, renal, and metabolic pipeline.

California, USA-based liver specialist 89bio saw its shares rocket more than 83% to $14.83 in pre-market activity on the news ...

The deal seeks to strengthen the drugmaker’s pipeline by adding an experimental treatment for a liver disease linked to ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of 89bio, Inc. (NASDAQ: ETNB) to Roche is fair to 89bio shareholders. Under the terms of the proposed transaction, ...

Basel, 18 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has entered into a definitive merger agreement to acquire 89bio, Inc. (Nasdaq: ETNB), a publicly listed ...